Stay updated with breaking news from Third Harmonic Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CAMBRIDGE, Mass., Aug. 09, 2022 (GLOBE NEWSWIRE) -- Third Harmonic Bio, Inc., a clinical-stage biopharmaceutical company developing a potent, highly selective, oral KIT inhibitor for the treatment of severe allergy
/PRNewswire/ -- Anjarium Biosciences AG ("Anjarium"), a biotech company focused on creating and delivering a new class of non-viral gene therapies, today...
TRADING UPDATES: Liontrust shareholders upset; RTW adds to portfolio | Financial News
Investegate announcements from RTW Venture Fund Ltd, New Investment in Third Harmonic Bio